Nisa Investment Advisors
TNXP icon

Nisa Investment Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

Nisa Investment Advisors’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$156K – 3123
2025
Q4 		$156K Sell
10,000
-4,800
-32% -$88.5K ﹤0.01% 1292
2025
Q3 		$358K Buy
+14,800
New +$549K ﹤0.01% 1111
2021
Q3 		– Hold
0
– -$46 – 2331
2021
Q2 		– Hold
0
– – – 1965

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Nisa Investment Advisors's TNXP Position: Q1 2026 in Review

Nisa Investment Advisors sold out of Tonix Pharmaceuticals (TNXP) in Q1 2026, closing a stake of 10,000 shares — an estimated $156K sold.

Nisa Investment Advisors first reported a position in TNXP in Q3 2025 and held it in 2 quarters. The position peaked at $358K in Q3 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Nisa Investment Advisors reported no remaining Tonix Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Nisa Investment Advisors sold 10,000 Tonix Pharmaceuticals shares in Q1 2026, an estimated $156K.
  • Nisa Investment Advisors first reported a position in Tonix Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Nisa Investment Advisors's Tonix Pharmaceuticals position peaked at $358K in Q3 2025.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.